RecruitingNot ApplicableNCT07378722

Rhythmic Auditory Stimulaton Using Personalized Music Therapy in Parkinson's Disease


Sponsor

Rumesa Butt

Enrollment

50 participants

Start Date

Feb 5, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Parkinson's disease (PD) is a progressive neurodegenerative disorder commonly associated with gait disturbances, balance impairments, and freezing of gait, which significantly increase the risk of falls and reduce functional independence. Conventional physical therapy improves mobility in individuals with PD; however, persistent gait deficits often remain. Rhythmic Auditory Stimulation (RAS) is an emerging, evidence-based intervention that uses external auditory cues to enhance gait timing, stride length, and movement initiation. This randomized controlled trial aims to evaluate the effectiveness of rhythmic auditory stimulation using personalized music therapy combined with conventional physical therapy compared to conventional physical therapy alone in individuals with Parkinson's disease. The primary outcomes include freezing of gait, gait velocity, and balance performance. Forty-two clinically diagnosed Parkinson's disease patients will be randomly allocated into two groups. Group A will receive conventional physical therapy, while Group B will receive rhythmic auditory stimulation using personalized music in addition to conventional therapy over an 8-week intervention period. The findings of this study may provide clinical evidence supporting the integration of personalized rhythmic auditory stimulation into rehabilitation programs for improving gait and balance in individuals with Parkinson's disease.


Eligibility

Min Age: 45 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether personalized music therapy using rhythmic auditory stimulation — where patients walk or move in time to music matched to their natural rhythm — can improve balance and gait (walking ability) in people with Parkinson's disease. **You may be eligible if...** - You have a clinical diagnosis of Parkinson's disease - You are between 45 and 55 years old - You do not have severe cognitive impairment (scored above 23 on the MMSE memory test) - You have mild balance impairment (Berg Balance Scale score of 21–40) **You may NOT be eligible if...** - You have a history of cancer, severe heart or respiratory disease, or significant vision or hearing loss - You have other neurological conditions that affect balance and walking - You have received neurological music therapy in the last 3 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALconventional physical therapy

GROUP A This group will receive the conventional physical therapy protocol for 8 weeks, they will receive treatment 3 times a week and the readings will be takenat baseline and at the end of 8 weeks of treatment. Total treatment sessions will be 24

BEHAVIORALRhythmic Auditory Stimulation (RAS)

Rhythmic Auditory Stimulation (RAS) will be delivered using personalized music selected according to each participant's preferred genre and synchronized to their individual walking cadence. Auditory cues will be provided through rhythmic music or a metronome embedded within the music to facilitate temporal gait regulation and motor entrainment. During gait training, participants will be instructed to synchronize their steps with the rhythmic auditory cues while walking overground. The RAS intervention will be administered three sessions per week for eight weeks, with each session lasting approximately 15-20 minutes and integrated into a conventional physical therapy program. The tempo of auditory cues will be adjusted progressively based on individual performance to encourage improvements in gait initiation, stride consistency, walking velocity, and reduction in freezing episodes. This intervention is designed to enhance gait automaticity and balance control in individuals with Parki


Locations(1)

Shadman Medical Center

Lahore, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07378722


Related Trials